1. Huang J, Wu R, Chen L, Yang Z, Yan D#, Li M#. Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect. Frontiers in Pharmacology13, (2022). #Corresponding Authors (IF: 5.810)
2. Zhu B, Zhong W, Cao X, Pan G, Xu M, Zheng J, Chen H, Feng X, Luo C, Lu C, Xiao J, Lin W, Lai C, Li M, Du X, Yi Q, Yan D. Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice. Sci Transl Med. 2022 Jan 26;14(629):eabh2548. doi: 10.1126/scitranslmed.abh2548. (IF: 17.956)
3. Zhong W, Cao X, Pan G, Niu Q, Feng X, Xu M, Li M, Huang Y, Yi Q, Yan D. ORP4L is a prerequisite for the induction of T-cell leukemogenesis associated with human T-cell leukemia virus 1. Blood. 2022 Feb 17;139(7):1052-1065. (IF: 22.113)
4. Li M, Russo M, Pirozzi F, Tocchetti CG, Ghigo A. Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities. Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118493. (IF: 4.739)
5. Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, Fiordelisi A, Napolitano F, Mercurio V, Sala V, Li M, Sorriento D, Ciccarelli M, Ghigo A, Hirsch E, Bianco R, Iaccarino G, Abete P, Bonaduce D, Calignano A, Berni Canani R, Tocchetti CG. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. Eur J Heart Fail. 2019 Apr;21(4):519-528. (IF：13.965)
6. Li M, Sala V, De Santis MC, Cimino J, Cappello P, Pianca N, Di Bona A, Margaria JP, Martini M, Lazzarini E, Pirozzi F, Rossi L, Franco I, Bornbaum J, Heger J, Rohrbach S, Perino A, Tocchetti CG, Lima BHF, Teixeira MM, Porporato PE, Schulz R, Angelini A, Sandri M, Ameri P, Sciarretta S, Lima-Júnior RCP, Mongillo M, Zaglia T, Morello F, Novelli F, Hirsch E, Ghigo A. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth. Circulation. 2018 Aug 14;138(7):696-711. (IF: 29.96)
7. Ghigo A, Laffargue M, Li M, Hirsch E. PI3K and Calcium Signaling in Cardiovascular Disease. Circ Res. 2017 Jul 21;121(3):282-292. (IF: 15.862)
8. Li M*, Murabito A*, Ghigo A, Hirsch E. PI3Ks in Diabetic Cardiomyopathy. J Cardiovasc Pharmacol. 2017 Dec;70(6):422-429. *equal contributors (IF: 2.371)
9. Ghigo A*, Li M*, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. BBA - Molecular Cell Research 2016 Jul;1863(7 Pt B):1916-25. *equal contributors (IF: 4.739)
10. Li M, Hirsch E. Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis. Cardiovascular Research. 2015, 105:129–130. (IF: 10.787)
11. Ghigo A, Li M. Phosphoinositide 3-kinase: Friend and foe in cardiovascular disease. Frontiers in Pharmacology 08/2015; 6:169. DOI:10.3389/fphar.2015.00169. (IF：3.845)
12. Li M-C*, Liu Q-Q*, Zhang Y-L, Wang L-L, Lu X-Y. Heterologous expression of human costimulatory molecule B7-2 and construction of B7-2 Immobilized PHA nanoparticles as immune activation agent. BMC Biotechnology. 2012. doi:10.1186/1472-6750-12-43. *equal contributors (IF：2.303)
*Equal first contributors, #Corresponding Authors.